Curso para aprender el lenguaje de programación JavaScript desde cero y para principiantes. +120 lecciones, 14 horas en vídeo y 220 ejercicios.
CERo Therapeutics (CERO) has dosed its seventh patient in the Phase 1 CERTAIN-T trial evaluating CER-1236 in blood cancers. This is the fourth patient in the second cohort. Investigators completed ...
NORTH PALM BEACH, Fla., Oct. 07, 2026 (GLOBE NEWSWIRE)-- SRX Global Inc. (NYSE American: SRXH) (the "Company" or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value ...
CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company’s lead development candidate is ...
View CERo Therapeutics Holdings stock forecast data, including CERO stock price estimates and 12-month CERo Therapeutics Holdings price targets, to assess potential upside or downside. Compare CERO ...
Phoenix Biotech Acquisition is a blank-check company that operates for the purpose of completing mergers, acquisitions, or similar transactions. It focuses on identifying and combining with businesses ...
From startups to enterprises, find AWS solutions scaled to your needs. Access tailored resources, pricing models, and support levels.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results